MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Agile Therapeutics Company Profile (NASDAQ:AGRX)

Consensus Ratings for Agile Therapeutics (NASDAQ:AGRX) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $16.80 (110.00% upside)

Analysts' Ratings History for Agile Therapeutics (NASDAQ:AGRX)
Show:
DateFirmActionRatingPrice TargetActions
5/31/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016FBR & Co.Reiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016RBC CapitalReiterated RatingOutperform$13.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2015Noble FinancialInitiated CoverageBuy -> Buy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015William BlairReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014Sterne Agee CRTInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2014Janney Montgomery ScottInitiated CoverageBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/31/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha